Regulated airway goblet cell mucin secretion

Area of Science:

• Respiratory Cell Biology
• Molecular Pharmacology
• Airway Secretion Mechanisms

Background:

• Mucin secretion by airway goblet cells is crucial for lung health.
• Nucleotide agonists acting on P2Y purinoceptors are key regulators of mucin release.
• Clara cells, recognized as significant mucin secretors, exhibit altered phenotypes during inflammation.

Purpose of the Study:

• To investigate the molecular mechanisms underlying regulated mucin secretion in airway goblet cells.
• To elucidate the roles of Munc13-2 and synaptotagmin 2 in mucin release pathways.
• To differentiate between baseline and agonist-induced mucin secretion mechanisms.

Main Methods:

• Utilized Munc13-2- and synaptotagmin 2-deficient mouse models.
• Examined molecular-level manipulations of proteins involved in regulated secretion.
• Employed well-differentiated primary human bronchial epithelial cell cultures.

Main Results:

• Munc13-2 regulates a baseline mucin secretion pathway in airways.
• Synaptotagmin 2 is essential for regulated mucin secretion, acting as a fast Ca2+ sensor for the SNARE complex.
• Data suggest the existence of two distinct pathways for exocytic mucin release from goblet cells.

Conclusions:

• Airway mucin secretion involves at least two distinct molecular pathways.
• Munc13-2 and synaptotagmin 2 play differential roles in baseline versus regulated mucin release.
• Understanding these pathways offers insights into airway inflammatory diseases and therapeutic targets.